{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Inherited white matter disorders",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_clonazepam",
          "name": "Clonazepam"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_carbamazepine",
          "name": "Carbamazepine"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_valproic_acid",
          "name": "Valproic Acid"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_phenytoin",
          "name": "Phenytoin"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_primidone",
          "name": "Primidone"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_lithium",
          "name": "Lithium"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_antidepressants",
          "name": "Antidepressants"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_antipsychotics",
          "name": "Antipsychotics"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_chlordiazepoxide",
          "name": "Chlordiazepoxide"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_benzodiazepines",
          "name": "Benzodiazepines"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_thioridazine",
          "name": "Thioridazine"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_sodium_oxybate",
          "name": "Sodium Oxybate"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [],
    "ranking": [],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_clonazepam",
          "type": "Drug",
          "label": "Clonazepam",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_carbamazepine",
          "type": "Drug",
          "label": "Carbamazepine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_valproic_acid",
          "type": "Drug",
          "label": "Valproic Acid",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_phenytoin",
          "type": "Drug",
          "label": "Phenytoin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_primidone",
          "type": "Drug",
          "label": "Primidone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lithium",
          "type": "Drug",
          "label": "Lithium",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_antidepressants",
          "type": "Drug",
          "label": "Antidepressants",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_antipsychotics",
          "type": "Drug",
          "label": "Antipsychotics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_chlordiazepoxide",
          "type": "Drug",
          "label": "Chlordiazepoxide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_benzodiazepines",
          "type": "Drug",
          "label": "Benzodiazepines",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thioridazine",
          "type": "Drug",
          "label": "Thioridazine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sodium_oxybate",
          "type": "Drug",
          "label": "Sodium Oxybate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_inherited_white_matter_disorders",
          "type": "Phenotype",
          "label": "Inherited White Matter Disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_cns_effect",
          "type": "Pathway",
          "label": "CNS Depression Risk",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adverse_effect",
          "type": "Phenotype",
          "label": "Exacerbated White Matter Disorders",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Clonazepam",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Carbamazepine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Valproic Acid",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Phenytoin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Primidone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Lithium",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Antidepressants",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Antipsychotics",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Chlordiazepoxide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Benzodiazepines",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Thioridazine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Sodium Oxybate",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_clonazepam",
          "target": "phenotype_inherited_white_matter_disorders",
          "relation": "associated_with",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知的药物-疾病关联"
        },
        {
          "source": "drug_carbamazepine",
          "target": "phenotype_inherited_white_matter_disorders",
          "relation": "associated_with",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "药物在类似条件下表现出负面影响"
        },
        {
          "source": "drug_valproic_acid",
          "target": "phenotype_inherited_white_matter_disorders",
          "relation": "associated_with",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "有文献报告显示潜在风险"
        },
        {
          "source": "drug_phenytoin",
          "target": "phenotype_inherited_white_matter_disorders",
          "relation": "associated_with",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "历史用药经验指向风险"
        },
        {
          "source": "drug_primidone",
          "target": "phenotype_inherited_white_matter_disorders",
          "relation": "associated_with",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "机制上可能加重此类疾病"
        },
        {
          "source": "drug_lithium",
          "target": "phenotype_inherited_white_matter_disorders",
          "relation": "associated_with",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "药物干预可能影响病理变化"
        },
        {
          "source": "drug_antidepressants",
          "target": "phenotype_inherited_white_matter_disorders",
          "relation": "associated_with",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "用药与疾病间有不良反应报道"
        },
        {
          "source": "drug_antipsychotics",
          "target": "phenotype_inherited_white_matter_disorders",
          "relation": "associated_with",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "有潜在影响的临床观察"
        },
        {
          "source": "drug_chlordiazepoxide",
          "target": "phenotype_inherited_white_matter_disorders",
          "relation": "associated_with",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "可能与疾病有所关联"
        },
        {
          "source": "drug_benzodiazepines",
          "target": "phenotype_inherited_white_matter_disorders",
          "relation": "associated_with",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "药物类别与表型研究相符"
        },
        {
          "source": "drug_thioridazine",
          "target": "phenotype_inherited_white_matter_disorders",
          "relation": "associated_with",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "顾及到药物的潜在影响"
        },
        {
          "source": "drug_sodium_oxybate",
          "target": "phenotype_inherited_white_matter_disorders",
          "relation": "associated_with",
          "weight": 0.3,
          "agent": "Proponent",
          "rationale": "不足够的证据支持其安全性"
        },
        {
          "source": "drug_clonazepam",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知催眠作用导致中枢神经抑制"
        },
        {
          "source": "drug_clonazepam",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "抑制作用可能加重白质病变"
        },
        {
          "source": "drug_carbamazepine",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "同类药物，引发中枢神经抑制"
        },
        {
          "source": "drug_carbamazepine",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "加重已有病症的风险"
        },
        {
          "source": "drug_valproic_acid",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "同样引起中枢抑制"
        },
        {
          "source": "drug_valproic_acid",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "可能导致预期外的病理变化"
        },
        {
          "source": "drug_phenytoin",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "已知中枢抑制作用"
        },
        {
          "source": "drug_phenytoin",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能对现有白质问题产生负面影响"
        },
        {
          "source": "drug_primidone",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "引发中枢神经抑制的潜在机制"
        },
        {
          "source": "drug_primidone",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "潜在对白质损害的加重"
        },
        {
          "source": "drug_lithium",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "影响神经传导，可能加重症状"
        },
        {
          "source": "drug_lithium",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "与当前病症的不良交互"
        },
        {
          "source": "drug_antidepressants",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致情绪促进对症状的反弹"
        },
        {
          "source": "drug_antidepressants",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.75,
          "agent": "提及已有白质病的伴随症状加重"
        },
        {
          "source": "drug_antipsychotics",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "对中枢神经的影响"
        },
        {
          "source": "drug_antipsychotics",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.75,
          "agent": "加重已有白质病症"
        },
        {
          "source": "drug_chlordiazepoxide",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "抑制中枢神经活动"
        },
        {
          "source": "drug_chlordiazepoxide",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.7,
          "agent": "可能加重相关症状"
        },
        {
          "source": "drug_benzodiazepines",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "已知风险，抑制中枢神经"
        },
        {
          "source": "drug_benzodiazepines",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.7,
          "agent": "加重白质相关症状"
        },
        {
          "source": "drug_thioridazine",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "对中枢神经有抑制作用"
        },
        {
          "source": "drug_thioridazine",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.65,
          "agent": "导致已有病症的加重"
        },
        {
          "source": "drug_sodium_oxybate",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "抑制神经活动"
        },
        {
          "source": "drug_sodium_oxybate",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.65,
          "agent": "风险考量可能性加重"
        }
      ],
      "round_index": 2
    },
    "history": {
      "round": 2
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_clonazepam",
          "name": "Clonazepam"
        },
        "score": 0.75,
        "graph_snapshot_ref": "GE_H1_round2",
        "key_assumptions": [
          "Clonazepam 的 CNS 抑制作用可能加重白质病变",
          "该药与卒中后并发症之间存在潜在联系"
        ],
        "caveats": [
          "需要更多针对特定人群的临床试验数据"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_carbamazepine",
          "name": "Carbamazepine"
        },
        "score": 0.74,
        "graph_snapshot_ref": "GE_H2_round2",
        "key_assumptions": [
          "对中枢神经的影响与白质损伤的相关性",
          "已有数据表明其加重已有白质疾患的风险"
        ],
        "caveats": [
          "缺乏对于长期用药的后果研究"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_valproic_acid",
          "name": "Valproic Acid"
        },
        "score": 0.72,
        "graph_snapshot_ref": "GE_H3_round2",
        "key_assumptions": [
          "该药对中枢神经的抑制作用与白质疾患之间存在潜在联系",
          "文献支持对于此类用药的安全性存疑"
        ],
        "caveats": [
          "机理尚需进一步探讨"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→CNS Effects→Exacerbated White Matter Disorders",
          "reason": "已知药物对中枢神经的抑制作用和与白质疾病的加重可能性"
        }
      ],
      "remaining_gaps": [
        "缺乏针对不同药物在Inherited White Matter Disorders上的临床试验数据"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "A",
            "B",
            "C",
            "D"
          ],
          "impact_summary": "为理解药物对脑白质的影响提供了基础"
        }
      ],
      "lessons": [
        "增加特定药物对特定表型影响的研究"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "增强PD疗效相关临床数据的展示"
      },
      {
        "role": "Skeptic",
        "patch": "为每个药物贡献不良反应的具体编制"
      },
      {
        "role": "Explorer",
        "patch": "保证新补助候选者的临床数据与主要目标一致"
      }
    ],
    "heuristics": [
      {
        "when": "评估影响白质的药物",
        "then": "重点关注其对中枢神经系统的副作用及文献支持"
      }
    ]
  }
}